Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | IDO1 | P14902 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | CES1 | P23141 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | BCHE | P06276 | 2/20 | 0.61 |
| ▸ | PTPRC | P08575 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL867585 | 0.80 | LMNA (0.46) | MEN1KMT2AMAPTKDM4EIDO1 | |
| SCHEMBL15542936 | 0.78 | LMNA (0.44) | MEN1KMT2AMAPTKDM4EIDO1 | |
| 1,2-Naphthoquinone SCHEMBL173316 | 0.76 | PTPRC (1.00) | MEN1KMT2AMAPTKDM4EIDO1 | |
| 1,2-Naphthoquinone SCHEMBL15167712 | 0.76 | PTPRC (1.00) | MEN1KMT2AMAPTKDM4EIDO1 | |
| 1,2-Naphthoquinone SCHEMBL29363665 | 0.76 | PTPRC (1.00) | MEN1KMT2AMAPTKDM4EIDO1 | |
| SCHEMBL7721084 | 0.76 | MEN1 (0.67) | MEN1KMT2AMAPTKDM4EIDO1 | |
| SCHEMBL7721082 | 0.76 | MEN1 (0.67) | MEN1KMT2AMAPTKDM4EIDO1 | |
| SCHEMBL154778 | 0.75 | ALDH1A1 (0.35) | MEN1KMT2AMAPTKDM4EIDO1 | |
| 1,2-Naphthoquinone SCHEMBL30697786 | 0.74 | PTPRC (0.95) | MEN1KMT2AMAPTKDM4EIDO1 | |
| 1,2-Naphthoquinone SCHEMBL30715501 | 0.74 | PTPRC (0.95) | MEN1KMT2AMAPTKDM4EIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5006223-A | Thermal cracking like fluid coking of feed stock to low boiling | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1991-04-09 | — | — | US | claimed |
| JP-6009964-A | — | — | None | — | — | JP | disclosed |
| US-12018315-B2 | Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230242969-A1 | PEPTIDE NUCLEIC ACID FUNCTIONALIZED HYDROGEL MICRONEEDLES FOR SAMPLING AND DETECTION OF INTERSTITIAL FLUID NUCLEIC ACIDS | HOWARD HUGHES MEDICAL INSTITUTE | 2023-08-03 | — | — | US | disclosed |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| US-10649124-B2 | Composition including compound having mesogenic group, polymer and optically anisotropic body obtained by polymerizing polymerizable composition, and phase difference film | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20190025490-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3346304-A1 | COMPOSITION INCLUDING COMPOUND HAVING MESOGENIC GROUP, POLYMER AND OPTICALLY ANISOTROPIC BODY OBTAINED BY POLYMERIZING POLYMERIZABLE COMPOSITION, AND PHASE DIFFERENCE FILM | DIC Corporation (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | DIC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20170247725-A1 | IN VIVO AND IN VITRO OLEFIN CYCLOPROPANATION CATALYZED BY HEME ENZYMES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-08-31 | — | — | US | disclosed |
| WO-2017079867-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-05-18 | — | — | WO | disclosed |
| US-9493799-B2 | In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-11-15 | — | — | US | disclosed |
| US-20160248114-A1 | QUINONE AND HYDROQUINONE BASED FLOW BATTERY | U.S. DEPARTMENT OF ENERGY | 2016-08-25 | — | — | US | disclosed |
| US-20160032330-A1 | P-450-CATALYZED ENANTIOSELECTIVE CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-02-04 | — | — | US | disclosed |
| US-20160002682-A1 | IN VIVO AND IN VITRO OLEFIN CYCLOPROPANATION CATALYZED BY HEME ENZYMES | UNITED STATES DEPARTMENT OF ENERGY | 2016-01-07 | — | — | US | disclosed |
| WO-2011029752-A1 | COMPOSITIONS FOR POLYMER BONDING | LOCTITE (R & D) LIMITED (IE) | 2011-03-17 | — | — | WO | disclosed |
| WO-2010106030-A1 | OXIDISING AGENTS FOR ELASTOMER BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2010-09-23 | — | — | WO | disclosed |
| JP-H069964-A | THERMAL CONVERSION OF PETROLEUM FEED | EXXON RES & ENG CO | 1994-01-18 | — | — | JP | disclosed |
| US-5006223-A | Thermal cracking like fluid coking of feed stock to low boiling | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1991-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919870-B2 | Polymerizable compound and optically anisotropic body | ZYX, ZW10, DPY30 | MEN1 2026/4885KMT2A 2769/4885MAPT 545/4885 |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | SMC4, MAP1LC3C, ZW10 | MEN1 1581/4885KMT2A 3183/4885MAPT 27/4885 |
| US-11046889-B2 | Polymerizable compound and optically anisotropic body | OCIAD1, RCC1, OCIAD2 | MEN1 2528/4885KMT2A 4308/4885MAPT 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.